Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma

Fig. 2

Verification of the effectiveness of the prediction model. Kaplan–Meier survival curve of different cohorts, including training set (A), GSE31210 (B), GSE30219 (C), GSE50081 (D), GSE13213 (E), GSE19188 (F), and GSE41271 (G) cohorts. Kaplan–Meier curve between high- and low-risk groups in TCGA-LUAD (H), GSE31210 (I), GSE30219 (J), GSE50081 (K), GSE13213 (L), GSE19188 (M), and GSE41271 (N) cohorts. O Univariate Cox analysis was employed to evaluate the correlation between risk score and prognosis of LUAD in each cohort

Back to article page